These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33063789)

  • 1. Association Between Physical Activity Levels and Chemotherapy-Induced Peripheral Neuropathy Severity in Cancer Survivors.
    Wilcoxon A; Kober KM; Viele C; Topp K; Smoot B; Abrams G; Chesney M; Paul SM; Conley YP; Levine JD; Miaskowski C
    Oncol Nurs Forum; 2020 Nov; 47(6):703-719. PubMed ID: 33063789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
    Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
    Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
    Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
    Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities in the Neuropathy Phenotype of Cancer Survivors Who Received Different Classes of Chemotherapy Drugs.
    Miaskowski C; Levine JD; Paul SM; Cooper B; Abrams G; Topp K; Cheung S; Henderson-Sabes J; Conley YP; Snowberg K; Alfaro E; Quinn M; Kober KM
    J Pain; 2022 Sep; 23(9):1604-1615. PubMed ID: 35533976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deleterious Effects of Higher Body Mass Index on Subjective and Objective Measures of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors.
    Petrovchich I; Kober KM; Wagner L; Paul SM; Abrams G; Chesney MA; Topp K; Smoot B; Schumacher M; Conley YP; Hammer M; Levine JD; Miaskowski C
    J Pain Symptom Manage; 2019 Aug; 58(2):252-263. PubMed ID: 31047960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-Induced Neuropathy in Cancer Survivors.
    Miaskowski C; Mastick J; Paul SM; Topp K; Smoot B; Abrams G; Chen LM; Kober KM; Conley YP; Chesney M; Bolla K; Mausisa G; Mazor M; Wong M; Schumacher M; Levine JD
    J Pain Symptom Manage; 2017 Aug; 54(2):204-218.e2. PubMed ID: 28063866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
    Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
    Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.
    McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB
    Support Care Cancer; 2019 Oct; 27(10):3849-3857. PubMed ID: 30756229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.
    Mizrahi D; Goldstein D; Trinh T; Li T; Timmins HC; Harrison M; Marx GM; Hovey EJ; Lewis CR; Friedlander M; Park SB
    Asia Pac J Clin Oncol; 2023 Feb; 19(1):243-249. PubMed ID: 35879821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy.
    Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB
    Gait Posture; 2021 Sep; 89():178-185. PubMed ID: 34320441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.
    Kanda K; Fujimoto K; Mochizuki R; Ishida K; Lee B
    BMC Cancer; 2019 Sep; 19(1):904. PubMed ID: 31506070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Analgesic Use Patterns Among Cancer Survivors With Chronic Chemotherapy-Induced Peripheral Neuropathy.
    Knoerl R; Sohn MB; Foust M; Francar L; O'Rourke MA; Morrow GM; Mustian KM; Gauthier L; Gewandter JS
    Oncol Nurs Forum; 2024 Aug; 51(5):445-450. PubMed ID: 39162787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
    Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Exercise on Symptoms of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Systematic Review and Meta-Analysis.
    Khmethong U; Hawsawi S; Kraenzle Schneider J
    Oncol Nurs Forum; 2024 Aug; 51(5):426-444. PubMed ID: 39162786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
    Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
    JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Physical Therapy Referral and Subsequent Attendance Among Childhood Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy at a Regional Childhood Cancer Survivorship Clinic.
    Kang L; Kadan-Lottick NS; Rotatori J; Kujawski SE; Messerschmidt E; Auerbach C; Balsamo LM; Lustberg MB; Ma X; Rodwin RL
    Semin Oncol Nurs; 2024 Oct; 40(5):151716. PubMed ID: 39164160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study.
    McNeish BL; Dittus K; Mossburg J; Krant N; Steinharter JA; Feb K; Cote H; Hehir MK; Reynolds R; Redfern MS; Rosano C; Richardson JK; Kolb N
    J Geriatr Oncol; 2024 May; 15(4):101765. PubMed ID: 38581957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.
    Winters-Stone KM; Horak F; Jacobs PG; Trubowitz P; Dieckmann NF; Stoyles S; Faithfull S
    J Clin Oncol; 2017 Aug; 35(23):2604-2612. PubMed ID: 28586243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry.
    Bonhof CS; van de Poll-Franse LV; Vissers PAJ; Wasowicz DK; Wegdam JA; Révész D; Vreugdenhil G; Mols F
    Psychooncology; 2019 Sep; 28(9):1926-1933. PubMed ID: 31293046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.